Invention Grant
- Patent Title: Abiraterone steroid formulation
-
Application No.: US15345410Application Date: 2016-11-07
-
Publication No.: US10292990B2Publication Date: 2019-05-21
- Inventor: Paul Nemeth , Matt Callahan , H. William Bosch , Marck Norret
- Applicant: SUN PHARMA GLOBAL FZE
- Applicant Address: AE Sharjah
- Assignee: SUN PHARMA GLOBAL FZE
- Current Assignee: SUN PHARMA GLOBAL FZE
- Current Assignee Address: AE Sharjah
- Agency: Medler Ferro Woodhouse & Mills PLLC
- Main IPC: A61K9/14
- IPC: A61K9/14 ; A61K31/58 ; A61K31/573 ; A61K45/06
Abstract:
A nanoparticulate composition of abiraterone acetate that allows treatment at a lower dose than convention abiraterone acetate formulations is described as in a method of treating prostate cancer by administering the composition together with a glucocorticoid.
Public/Granted literature
- US20170049788A1 Abiraterone Steroid Formulation Public/Granted day:2017-02-23
Information query
